These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 9889570
21. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Brunham RC, Rey-Ladino J. Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042 [Abstract] [Full Text] [Related]
22. Trachoma research: laboratory and epidemiologic aspects. Taylor HR. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1987 Feb; (64):25-58. PubMed ID: 3332726 [No Abstract] [Full Text] [Related]
23. Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. Caldwell HD, Kuo CC, Kenny GE. J Immunol; 1975 Oct; 115(4):963-8. PubMed ID: 1080772 [Abstract] [Full Text] [Related]
28. CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques. Olivares-Zavaleta N, Whitmire WM, Kari L, Sturdevant GL, Caldwell HD. J Immunol; 2014 May 15; 192(10):4648-54. PubMed ID: 24711617 [Abstract] [Full Text] [Related]
29. Pathogenesis of trachoma: the stimulus for inflammation. Taylor HR, Johnson SL, Schachter J, Caldwell HD, Prendergast RA. J Immunol; 1987 May 01; 138(9):3023-7. PubMed ID: 3571982 [Abstract] [Full Text] [Related]
31. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Barker CJ, Beagley KW, Hafner LM, Timms P. Vaccine; 2008 Mar 04; 26(10):1285-96. PubMed ID: 18261829 [Abstract] [Full Text] [Related]
32. Towards a safe and effective chlamydial vaccine: lessons from the eye. Mabey DC, Hu V, Bailey RL, Burton MJ, Holland MJ. Vaccine; 2014 Mar 20; 32(14):1572-8. PubMed ID: 24606636 [Abstract] [Full Text] [Related]
34. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes. Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO. FEMS Immunol Med Microbiol; 2007 Feb 20; 49(1):46-55. PubMed ID: 17094789 [Abstract] [Full Text] [Related]
35. Evaluation of serological tests for screening of chlamydial eye diseases. Numazaki K, Chiba S, Aoki K. In Vivo; 1999 Feb 20; 13(3):235-7. PubMed ID: 10459498 [Abstract] [Full Text] [Related]
36. Development of immunity to ocular chlamydial infection. Taylor HR. Am J Trop Med Hyg; 1990 Apr 20; 42(4):358-64. PubMed ID: 2331044 [Abstract] [Full Text] [Related]
37. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. Perry LL, Su H, Feilzer K, Messer R, Hughes S, Whitmire W, Caldwell HD. J Immunol; 1999 Mar 15; 162(6):3541-8. PubMed ID: 10092812 [Abstract] [Full Text] [Related]
39. Overview of Chlamydia trachomatis infection and the requirements for a vaccine. Schachter J. Rev Infect Dis; 1985 Mar 15; 7(6):713-6. PubMed ID: 3840910 [Abstract] [Full Text] [Related]